4-((3-((Cyclopropylmethyl)carbamoyl)-2-methoxyphenyl)-amino)-6-((5-fluoro-4-methyl-pyridin-2-yl)amino)-N-methylnicotinamide

ID: ALA4527672

PubChem CID: 155544232

Max Phase: Preclinical

Molecular Formula: C25H27FN6O3

Molecular Weight: 478.53

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CNC(=O)c1cnc(Nc2cc(C)c(F)cn2)cc1Nc1cccc(C(=O)NCC2CC2)c1OC

Standard InChI:  InChI=1S/C25H27FN6O3/c1-14-9-21(29-13-18(14)26)32-22-10-20(17(12-28-22)24(33)27-2)31-19-6-4-5-16(23(19)35-3)25(34)30-11-15-7-8-15/h4-6,9-10,12-13,15H,7-8,11H2,1-3H3,(H,27,33)(H,30,34)(H2,28,29,31,32)

Standard InChI Key:  FXNUIYODKGAABX-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 35 38  0  0  0  0  0  0  0  0999 V2000
    4.6458  -15.2748    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6447  -16.0944    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3527  -16.5033    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.0624  -16.0939    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0596  -15.2712    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3510  -14.8660    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7708  -16.5014    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.4778  -16.0917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1828  -16.4996    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8894  -16.0906    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8886  -15.2725    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1753  -14.8652    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4716  -15.2766    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.5951  -14.8619    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    5.3485  -14.0488    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.9380  -14.8664    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9378  -14.0492    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.2304  -15.2752    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.5226  -14.8667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0550  -13.6381    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7618  -14.0469    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4678  -13.6369    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4658  -12.8188    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7519  -12.4125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0488  -12.8249    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3382  -12.4214    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.6335  -12.8351    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5976  -16.4984    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7466  -11.5954    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4516  -11.1822    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.0362  -11.1914    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.1620  -11.5862    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8670  -11.1730    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6823  -11.1670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2691  -10.4620    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  4  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
 11 14  1  0
  6 15  1  0
  1 16  1  0
 16 17  2  0
 16 18  1  0
 18 19  1  0
 15 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 20  1  0
 25 26  1  0
 26 27  1  0
 10 28  1  0
 24 29  1  0
 29 30  1  0
 29 31  2  0
 30 32  1  0
 32 33  1  0
 34 33  1  0
 35 34  1  0
 33 35  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4527672

    ---

Associated Targets(Human)

JAK1 Tclin JAK1/TYK2 (259 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TYK2 Tclin Tyrosine-protein kinase TYK2 (5029 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 478.53Molecular Weight (Monoisotopic): 478.2129AlogP: 3.92#Rotatable Bonds: 9
Polar Surface Area: 117.27Molecular Species: NEUTRALHBA: 7HBD: 4
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 13.16CX Basic pKa: 6.91CX LogP: 4.33CX LogD: 4.32
Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.37Np Likeness Score: -1.05

References

1. Wrobleski ST, Moslin R, Lin S, Zhang Y, Spergel S, Kempson J, Tokarski JS, Strnad J, Zupa-Fernandez A, Cheng L, Shuster D, Gillooly K, Yang X, Heimrich E, McIntyre KW, Chaudhry C, Khan J, Ruzanov M, Tredup J, Mulligan D, Xie D, Sun H, Huang C, D'Arienzo C, Aranibar N, Chiney M, Chimalakonda A, Pitts WJ, Lombardo L, Carter PH, Burke JR, Weinstein DS..  (2019)  Highly Selective Inhibition of Tyrosine Kinase 2 (TYK2) for the Treatment of Autoimmune Diseases: Discovery of the Allosteric Inhibitor BMS-986165.,  62  (20): [PMID:31318208] [10.1021/acs.jmedchem.9b00444]

Source